Burkholderia cenocepacia lectin A binding to heptoses from the bacterial lipopolysaccharide

Roberta Marchetti1, Lenka Malinovska, Emilie Lameignère

  • 1Dipartimento di Scienze Chimiche, Università di Napoli "Federico II", Italy.

Glycobiology
|July 6, 2012
PubMed

Insights

Burkholderia cenocepacia lectin BC2L-A binds to mannose-configured sugars, revealing potential targets on the bacterial surface. This interaction is crucial for understanding infections in cystic fibrosis patients.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • The Burkholderia cepacia complex (Bcc) causes severe pneumonia in cystic fibrosis (CF) patients.
  • Burkholderia cenocepacia, a dangerous Bcc member, leads to high morbidity and mortality in CF, including

Purpose of the Study:

  • To investigate the interaction of the Burkholderia cenocepacia lectin BC2L-A with specific carbohydrate structures.
  • To elucidate the binding requirements and structural basis of BC2L-A-carbohydrate interactions.

Main Methods:

  • Saturation transfer difference NMR spectroscopy was used to study lectin-carbohydrate binding.
  • X-ray crystallography provided structural insights into the BC2L-A-heptoside complex.
  • Isothermal titration calorimetry assessed binding affinities with various saccharides.
  • Fluorescence microscopy demonstrated lectin binding to bacterial surfaces.

Main Results:

  • BC2L-A requires mannose configuration with a C6 hydroxyl or glycol group for binding.
  • Crystal structure confirmed carbohydrate binding site interactions and orientation.
  • Calorimetry showed BC2L-A binds to heptose-containing oligosaccharides and polysaccharides from bacterial cell walls.
  • Fluorescent BC2L-A specifically binds to the surface of B. cenocepacia.

Conclusions:

  • BC2L-A recognizes specific mannose-configured epitopes, likely on the B. cenocepacia cell surface.
  • Understanding these interactions may inform therapeutic strategies against Bcc infections in CF patients.